US20200123605A1 - Sequencing by synthesis using pulse read optics - Google Patents
Sequencing by synthesis using pulse read optics Download PDFInfo
- Publication number
- US20200123605A1 US20200123605A1 US16/724,574 US201916724574A US2020123605A1 US 20200123605 A1 US20200123605 A1 US 20200123605A1 US 201916724574 A US201916724574 A US 201916724574A US 2020123605 A1 US2020123605 A1 US 2020123605A1
- Authority
- US
- United States
- Prior art keywords
- wells
- deblock
- light
- primer
- nucleotide analog
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000012163 sequencing technique Methods 0.000 title claims abstract description 36
- 238000003786 synthesis reaction Methods 0.000 title abstract description 12
- 230000015572 biosynthetic process Effects 0.000 title abstract description 11
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 92
- 230000000903 blocking effect Effects 0.000 claims abstract description 52
- 238000000034 method Methods 0.000 claims abstract description 52
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 19
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 19
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 19
- 230000003287 optical effect Effects 0.000 claims description 76
- 239000000758 substrate Substances 0.000 claims description 22
- -1 o-nitrobenzyl Chemical group 0.000 claims description 19
- 238000004891 communication Methods 0.000 claims description 17
- 239000011541 reaction mixture Substances 0.000 claims description 12
- 238000004590 computer program Methods 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- 230000003213 activating effect Effects 0.000 claims description 5
- 229910052581 Si3N4 Inorganic materials 0.000 claims description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 2
- NRTOMJZYCJJWKI-UHFFFAOYSA-N Titanium nitride Chemical compound [Ti]#N NRTOMJZYCJJWKI-UHFFFAOYSA-N 0.000 claims description 2
- FUWMBNHWYXZLJA-UHFFFAOYSA-N [Si+4].[O-2].[Ti+4].[O-2].[O-2].[O-2] Chemical compound [Si+4].[O-2].[Ti+4].[O-2].[O-2].[O-2] FUWMBNHWYXZLJA-UHFFFAOYSA-N 0.000 claims description 2
- PMHQVHHXPFUNSP-UHFFFAOYSA-M copper(1+);methylsulfanylmethane;bromide Chemical compound Br[Cu].CSC PMHQVHHXPFUNSP-UHFFFAOYSA-M 0.000 claims description 2
- 239000011521 glass Substances 0.000 claims description 2
- 229910000449 hafnium oxide Inorganic materials 0.000 claims description 2
- WIHZLLGSGQNAGK-UHFFFAOYSA-N hafnium(4+);oxygen(2-) Chemical compound [O-2].[O-2].[Hf+4] WIHZLLGSGQNAGK-UHFFFAOYSA-N 0.000 claims description 2
- 229910000484 niobium oxide Inorganic materials 0.000 claims description 2
- URLJKFSTXLNXLG-UHFFFAOYSA-N niobium(5+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[Nb+5].[Nb+5] URLJKFSTXLNXLG-UHFFFAOYSA-N 0.000 claims description 2
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 claims description 2
- BPUBBGLMJRNUCC-UHFFFAOYSA-N oxygen(2-);tantalum(5+) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[Ta+5].[Ta+5] BPUBBGLMJRNUCC-UHFFFAOYSA-N 0.000 claims description 2
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 claims description 2
- 229920003023 plastic Polymers 0.000 claims description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims description 2
- 239000004417 polycarbonate Substances 0.000 claims description 2
- 229920000515 polycarbonate Polymers 0.000 claims description 2
- 239000004926 polymethyl methacrylate Substances 0.000 claims description 2
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 claims description 2
- 229910001936 tantalum oxide Inorganic materials 0.000 claims description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims description 2
- 229910001928 zirconium oxide Inorganic materials 0.000 claims description 2
- 239000002773 nucleotide Substances 0.000 abstract description 42
- 206010021033 Hypomenorrhoea Diseases 0.000 abstract description 4
- 240000007320 Pinus strobus Species 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 11
- 238000001514 detection method Methods 0.000 description 11
- 238000010511 deprotection reaction Methods 0.000 description 10
- 238000005516 engineering process Methods 0.000 description 8
- 238000012544 monitoring process Methods 0.000 description 8
- 238000010348 incorporation Methods 0.000 description 7
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 6
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 6
- 229920001519 homopolymer Polymers 0.000 description 6
- 108091034117 Oligonucleotide Proteins 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 230000000116 mitigating effect Effects 0.000 description 4
- 230000008832 photodamage Effects 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000001712 DNA sequencing Methods 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 230000003467 diminishing effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 238000013178 mathematical model Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- 241000721701 Lynx Species 0.000 description 1
- 102100030569 Nuclear receptor corepressor 2 Human genes 0.000 description 1
- 101710153660 Nuclear receptor corepressor 2 Proteins 0.000 description 1
- 239000012082 adaptor molecule Substances 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 235000019689 luncheon sausage Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 230000005257 nucleotidylation Effects 0.000 description 1
- 238000002161 passivation Methods 0.000 description 1
- 230000002974 pharmacogenomic effect Effects 0.000 description 1
- 238000012175 pyrosequencing Methods 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 238000004557 single molecule detection Methods 0.000 description 1
- 230000007019 strand scission Effects 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
- B01L3/5085—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B60/00—Apparatus specially adapted for use in combinatorial chemistry or with libraries
- C40B60/08—Integrated apparatus specially adapted for both creating and screening libraries
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6452—Individual samples arranged in a regular 2D-array, e.g. multiwell plates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/648—Specially adapted constructive features of fluorimeters using evanescent coupling or surface plasmon coupling for the excitation of fluorescence
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00279—Features relating to reactor vessels
- B01J2219/00306—Reactor vessels in a multiple arrangement
- B01J2219/00313—Reactor vessels in a multiple arrangement the reactor vessels being formed by arrays of wells in blocks
- B01J2219/00315—Microtiter plates
- B01J2219/00317—Microwell devices, i.e. having large numbers of wells
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/0068—Means for controlling the apparatus of the process
- B01J2219/00686—Automatic
- B01J2219/00689—Automatic using computers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/0068—Means for controlling the apparatus of the process
- B01J2219/00702—Processes involving means for analysing and characterising the products
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00709—Type of synthesis
- B01J2219/00711—Light-directed synthesis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00722—Nucleotides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/0627—Sensor or part of a sensor is integrated
- B01L2300/0654—Lenses; Optical fibres
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0829—Multi-well plates; Microtitration plates
Definitions
- the systems and methods provide a plurality of deblock-scan cycles comprising an initial deblock time period followed by a scanning light period, wherein at least one of the following occurs in each deblock-scan cycle: 1) the deblock time period is shorter than the scan time period; 2) the deblock time period is only long enough to deblock the photolabile groups that are part of a primer in less than all of the plurality of wells; or 3) the deblock time period is between 25 and 150 mSec and the scan time is at least 200 mSec.
- Such shorter deblock time periods help prevent the addition of more than one nucleotide to the primer prior to scanning (e.g., accuracy is enhanced).
- the time period needed for complete deblocking is relatively long, while the time period of nucleotide incorporation is relatively fast.
- additional nucleotides may be incorporated onto the end of the primer sequence before they can be scanned and detected. Therefore, the accuracy of the sequencing reaction may be compromised.
- the systems and methods provide a plurality of deblock-scan cycles comprising an initial deblock time period followed by a scanning light period, wherein at least one of the following occurs in each deblock-scan cycle: 1) the deblock time period is shorter than the scan time period; 2) the deblock time period is only long enough to deblock the photolabile groups that are part of a primer in less than all of the plurality of wells; or 3) the deblock time period is between 25 and 150 mSec and the scan time is at least 200 mSec.
- Such shorter deblock time periods help prevent the addition of more than one nucleotide to the primer prior to scanning (e.g., accuracy is enhanced).
- systems for photocleaving and scanning nucleotide analogs comprising: a) a substrate comprising a plurality of wells which each contain, or are configured to contain, a reaction mixture comprising a template nucleic acid, a polymerase, a primer hybridized to the template, and a first nucleotide analog, wherein the primer comprises a 3′ terminal nucleotide analog with a photolabile blocking group that terminates chain extension, and wherein the first nucleotide analog comprises: i) a first detectable moiety, and ii) a photolabile blocking group that terminates chain extension; and b) a light system component comprising: i) a light source in optical communication with the plurality of wells which is configured to provide: A) photocleaving light input that cleaves the photolabile blocking group when it is part of the primer; and B) scanning input light that provides an optical signal from the first detectable moiety after the first nucleotide analog is added to
- a light component comprising a light component, wherein the light component is configured to optically interface with a substrate component, wherein the substrate component comprises a plurality of wells, wherein each well contains, or is configured to contain, a reaction mixture comprising a template nucleic acid, a polymerase, a primer hybridized to the template, and a first nucleotide analog, wherein the primer comprises a 3′ terminal nucleotide analog with a photolabile blocking group that terminates extension, and wherein the first nucleotide analog comprises: i) a detectable moiety, and ii) a photolabile blocking group that terminates chain extension; and wherein the light component comprises: a) a light source in optical communication with the plurality of wells that provides: A) photocleaving light input that cleaves the photolabile blocking group when it is part of the primer; and B) scanning input light that produces an optical signal from the first detectable moiety after the first nucleotide analog is added to the
- a system comprising: i) a substrate comprising a plurality of wells, wherein each well contains a reaction mixture comprising a template nucleic acid, a polymerase, a primer hybridized to the template, and a first nucleotide analog, wherein the primer comprises a 3′ terminal nucleotide analog with a photolabile blocking group that terminates chain extension, and wherein the first nucleotide analog comprises: i) a first detectable moiety, and ii) a photolabile blocking group that terminates chain extension; and ii) a light system component comprising: A) a light source in optical communication with the plurality of wells, wherein the light source provides: I) photocleaving light input; and II) scanning light input; B) a light control component that activates the light source such that a plurality of deblock-scan cycles are generated which comprise: I) an initial deblock
- a light component comprising a light component, wherein the light component is configured to optically interface with a substrate component, wherein the substrate component comprises a plurality of wells (e.g., optical sensing wells), wherein each of the wells is sized to provide an internal waveguide (e.g., a zero mode waveguide) and/or is optically coupled to an external waveguide (e.g., a planar waveguide), wherein each well contains, or is configured to contain, a reaction mixture comprising a template nucleic acid, a polymerase, a primer hybridized to the template, and a first nucleotide analog, wherein the primer comprises a 3′ terminal nucleotide analog with a photolabile blocking group that terminates extension, and wherein the first nucleotide analog comprises: i) a detectable moiety, and ii) a photolabile blocking group that terminates chain extension; and wherein the light component comprises: a) a light source in optical communication with the
- systems for system for photocleaving and scanning nucleotide analogs comprising: a) a substrate comprising a plurality of optical sensing wells, wherein each of the optical sensing wells is sized to provide an internal waveguide and/or is optically coupled to an external waveguide, wherein each optical sensing well contains, or is configured to contain, a reaction mixture comprising a template nucleic acid, a polymerase, a primer hybridized to the template, and a first nucleotide analog, wherein the primer comprises a 3′ terminal nucleotide analog with a photolabile blocking group that terminates chain extension, and wherein the first nucleotide analog comprises: i) a first detectable moiety, and ii) a photolabile blocking group that terminates chain extension; and b) a light system component comprising: i) a light source in optical communication with the internal and/or external waveguides, wherein the light source is configured to provide: A) photoclea
- a system comprising: i) a substrate comprising a plurality of optical sensing wells, wherein each of the optical sensing wells is sized to provide an internal waveguide and/or is optically coupled to an external waveguide, wherein each optical sensing well contains a reaction mixture comprising a template nucleic acid, a polymerase, a primer hybridized to the template, and a first nucleotide analog, wherein the primer comprises a 3′ terminal nucleotide analog with a photolabile blocking group that terminates chain extension, and wherein the first nucleotide analog comprises: i) a first detectable moiety, and ii) a photolabile blocking group that terminates chain extension; and ii) a light system component comprising: A) a light source in optical communication with the internal and/or external waveguides, wherein the light source provides: I) photocleaving light input that generates
- the detecting provides sequence information for at least a portion of the template nucleic acid in at least some of the plurality of wells (e.g., the identity of 5 bases . . . 10 bases . . . or more; or the complete sequence of the template).
- the light control component comprises a user interface, and wherein the activating is performed by a user through the user interface.
- the user interface comprises a computer keyboard and/or computer mouse.
- the methods are performed without any washing step (e.g., single reaction mixture in well during entire sequence by synthesis reaction).
- the systems further comprise c) a detector component in optical communication with the plurality of wells which is capable of detecting the optical signal from the plurality of wells.
- the system further comprises a filter, where said optical signal passes through said filter prior to being detected by said detector.
- the light control component comprises a computer processor and a computer program embedded within the computer processor, wherein the computer program that controls the light source such that the plurality of deblock-scan cycles are generated.
- the substrate is composed of a material selected from the group consisting of: transparent glass, transparent plastic, silicon-titanium oxide, titanium oxide, tantalum oxide, niobium oxide, hafnium oxide, aluminum oxide, zirconium oxide, silicon nitride, aluminum nitride, titanium nitride, polycarbonate (PC), PMMA, or Su8.
- the plurality of wells comprises at least 5 wells (e.g., at least 5 . . . 25 . . . 100 . . . 250 . . 500 . . . 1000 . . . 2000 . . . 4000 . . . 8000 . . . 50,000 . . . or more).
- the plurality of wells are sized to provide an internal waveguide (e.g., an internal waveguide at the bottom of said wells).
- each of the plurality of wells comprises a zero-mode waveguide.
- the systems further comprise one or a plurality of external waveguides (e.g., an external waveguide for each of the plurality of optically sensing wells).
- the plurality of wells have a volume between 200 nanoliters and 10 zeptoliters.
- the plurality of wells are optically coupled to an external waveguide.
- each of the wells contains the reaction mixture.
- the template nucleic acid in each of the plurality of wells is part of a sequencing library (e.g., human genomic sequencing library).
- the photolabile blocking group that is part of the primer is the same as, or different from, the photolabile blocking group that is part of the first nucleotide analog.
- the reaction mixture further comprises a second nucleotide analog (e.g., a second type of nucleotides analog) comprising a photolabile locking group and a second detectable moiety different from the first detectable moiety, wherein the first and second nucleotide analogs have different bases (e.g., selected from guanine, cytosine, adenine, and thymine).
- the polymerase comprises a Phi29 polymerase or mutant thereof.
- the first detectable moiety comprises a fluorescent dye.
- the photolabile blocking group is selected from the group consisting of: an o-nitrobenzyl blocking group, nitroveratryl, 1-pyrenylmethyl, 6-nitroveratryloxycarbonyl, dimethyldimethoxybenzyloxycarbonyl, 2-nitrobenzyloxycarbonyl, 5-bromo-7-nitroindolinyl, P-hydroxy-alpha-methyl-cinnamoyl, methyl, 6-nitroveratryloxycarbonyl, methyl-6-nitropiperonyloxycarbonyl, and 2-oxymethylene anthraquinone, dimethoxybenzyloxy carbonyl, 5-bromo-7-nitroindolinyl, o-hydroxy-alpha-methyl cinnamoyl, and 2-oxymethylene anthriquinone.
- the light source comprises a first light generating component configured to generate the photocleaving light input, and a second light generating component configured to generate the scanning light input. In other embodiments, the light source comprises a light generating component configured to alternately generate both the photocleaving light input and the scanning light input. In additional embodiments, the photocleaving light input has a wavelength between 300 nm and 2000 nm (e.g., 300 nm . . . 500 nm . . . 800 nm . . . 1200 nm . . . 1500 nm . . . and 2000 nm).
- the scanning light input has a wavelength between 230 nm and 1000 nm (e.g., 230 nm 450 . . . 680 . . . 850 . . . and 1000 nm).
- the photocleaving light input has a wavelength different than that of the scanning light input wavelength.
- the external waveguide comprises one or more planar waveguides.
- the plurality of wells are optically coupled to an external waveguide, wherein the external waveguide is either one waveguide in optical communication with all of the plurality of wells, or wherein the external waveguide is a plurality of waveguides, one for each of the plurality of wells.
- the first and/or second electromagnetic waves comprises an evanescent wave or a traveling field wave.
- the light control component comprises a user interface that allows a user to activate the light source.
- the plurality of deblock-scan cycles is at least five deblock-scan cycles (e.g., at least 5 . . . 10 . . . 15 . . . 25 . . . 100 . . . 1000 or more).
- the deblock time period is shorter than the scan time period.
- the deblock time period is 5% shorter than the scan time period (e.g., 5% . . . 15% . . . 25% . . . 50% . . . 68% . . . 75% . . . 90% . . . 95% . . . or 99% shorter).
- the deblock time period is only long enough to deblock the photolabile blocking groups that are part of the primer in less than all of the plurality of wells. In further embodiments, the deblock time period is only long enough to deblock the photolabile blocking groups that are part of the primer in about 7-12 percent, or about 12-25%, or about 25-55% of the plurality of wells. In certain embodiments, the deblock time period is between 15 and 150 mSec (e.g., 15 . . . 25 . . . 50 . . . 75 . . . 100 . . . 125 . . .
- the scan time is at least 200 mSec (e.g., at least 200 mSec . . . 500 mSec . . . 750 mSec . . . 1 second . . . 1.5 seconds . . . 2 seconds . . . 5 seconds . . . 10 seconds . . . or more).
- FIG. 1 shows the DT50 (time required to deblock 50% of the molecules) for a number of Lasergen dNTP analogues.
- FIG. 2 shows a decay curve for a blocked base ((S)-t-butyl-5-methoxy-2-nitrobenzyl dNTP) with a t 1/2 of 750 mSec.
- FIG. 3 shows, based on the curve in FIG. 2 , a deprotection time of 4.6 seconds is required to deprotect 98.5% of the dNTP's.
- FIG. 4 shows that a rapid light pulse of 100 msec, for example, could then be used to eliminate the problem of spurious base addition.
- FIG. 5 shows that, given the extension rate of standard DNA polymerase on a surface is approximately 5 bases/sec, it would be expected that the new base incorporated after the 100 msec pulse would be relatively rapid.
- FIG. 6 shows that the kinetics of deprotection can be derived from the standard decay curve, resulting in the deprotection ratio shown in this figure.
- FIG. 7 shows three strobe cycles, using 10 6 molecules in the binomial expansion model described in Example 1 below.
- FIGS. 8 a - i model 35 strobe cycles starting off with 10 6 target molecules on a surface as described in Example 1.
- FIG. 8 a models cycle 0 , where there are 10 6 molecules on the surface waiting to be deblocked.
- cycle 1 shown in FIG. 8 b
- FIG. 8 c shows 5 cycles
- FIG. 8 d shows 10 cycles
- FIG. 8 e shows 15 cycles
- FIG. 8 f shows 20 cycles.
- FIG. 8 f shows that a normal distribution is starting to appear.
- FIG. 8 f shows that a normal distribution is starting to appear. As shown in FIG.
- FIG. 8 g 25 cycles
- the distribution curve is slowly moving to the right, while the distribution itself is slowly diminishing and becoming more spread out, with each successive cycle.
- FIG. 8 h shows the distribution after 30 cycles.
- the normal distribution continues to diminish and spread out, much like Poisson distribution at high copy number.
- the 35 cycles in FIG. 8 i represents about 3 minutes of sequencing run time.
- FIG. 9 shows the results of extending cycle number out to 400 cycles (still using 100 mSec strobes of deblocking light), where each curve represents the distribution after 10 strobe cycles.
- FIG. 10 shows the results of extending the cycle number out to 400 cycles using 50 mSec strobes, where 4.4% of available photolabile bases are deblocked.
- FIG. 11 shows the distribution expected if 50% of the molecules deblock during the 100 msec pulse (as opposed to 8 . 8 %). Each curve represents the distribution after 10 strobe cycles.
- FIG. 12 shows a mathematical model for detecting homopolymers by short pulses of deprotecting light.
- the systems and methods provides a plurality of deblock-scan cycles comprising an initial deblock time period followed by a scanning light period, wherein at least one of the following occurs in each deblock-scan cycle: 1) the deblock time period is shorter than the scan time period; 2) the deblock time period is only long enough to deblock the photolabile groups that are part of a primer in less than all of the plurality of wells; or 3) the deblock time period is between 25 and 150 mSec and the scan time is at least 200 mSec.
- Such shorter deblock time periods help prevent the addition of more than one nucleotide to the primer prior to scanning (e.g., accuracy is enhanced).
- sequence by synthesis methods are employed. Exemplary sequencing methods are detailed further below.
- the deblock-scan cycles described herein are used with sequencing methodologies that employ Zero-mode waveguides (e.g., as produced by Pacific Biosciences).
- a sequencing by synthesis approach using a zero mode wave guide ZMWG and a photo-deblockable nucleotide is used to enable a single fluid sequencing by synthesis process.
- the ZMWG is used, for example, to both detect the detectably (e.g., flourescently) labeled nucleotide in the acceptor site of a polymerase and to selectively deblock this nucleotide while not deblocking the nucleotides in the reaction buffer that are outside the illumination field of the ZMWGs.
- detectably e.g., flourescently
- the challenge is the time domains for de-blocking (relatively slow) and nucleotide incorporation (relatively fast) may not be compatible for accurate sequencing as additional nucleotides may be incorporated during the relatively longer de-blocking step.
- the deblock-scan cycles described herein breakup the de-blocking time into pulses followed by reads. For example if it take 5 seconds to efficiently de-block 99% of the nucleotides in the polymerase and 200 mSec to incorporate a nucleotide, then one pulse (with photocleaving light) for a brief period of time, for example 50 mSec, and then read the base (using scanning light and a detector). In this way, changes in the nucleotide sequence are detected and the de-blocking time is, for example, significantly shorter than the incorporation time.
- the systems and methods described herein allows a single fluid (e.g., no washing required) single molecule sequencing by synthesis when the time domains for photo de-blocking and nucleotide incorporation are not compatible.
- the present description is not limited to any particular sequencing technology that can employ photolabile blocked nucleotides and the deblock-scan cycles described herein.
- the sequencing by synthesis methods employ waveguides (e.g., planar, zero-mode waveguides, etc.).
- waveguides e.g., planar, zero-mode waveguides, etc.
- such methods are described in the following publications: U.S. Pat. Nos. 7,476,504; 8,747,751; Pat. Pub. 20110306143; and Pat. Pub. 20120156100; all of which are herein incorporated by reference in their entireties. These four publications are specifically incorporated by reference, including the figures and descriptions of the figures, as if fully set forth herein.
- such methods utilizes reaction wells 50-100 nm in diameter and encompassing a reaction volume of approximately 20 zeptoliters (10 ⁇ 10 ⁇ 21 L). Sequencing reactions are performed using immobilized template, modified phi29 DNA polymerase, and high local concentrations of fluorescently labeled dNTPs. High local concentrations and continuous reaction conditions allow incorporation events to be captured in real time by fluor signal detection using laser excitation, an optical waveguide, and a CCD camera. With this technology, DNA sequencing is generally performed on SMRT chips, each containing thousands of zero-mode waveguides (ZMWs). A ZMW is a hole/well, tens of nanometers in diameter, fabricated in a 100 nm metal film deposited on a silicon dioxide substrate.
- ZMWs zero-mode waveguides
- Each ZMW becomes a nanophotonic visualization chamber providing a detection volume of just 20 zeptoliters (10-21 liters). At this volume, the activity of a single molecule is detected amongst a background of thousands of labeled nucleotides.
- the ZMW provides a window for watching DNA polymerase as it performs sequencing by synthesis.
- a single DNA polymerase molecule is attached to the bottom surface such that it permanently resides within the detection volume.
- Phospholinked nucleotides (would be blocked with photolabile blocking groups for the systems and methods described herein), each type labeled with a different colored fluorophore, are then introduced into the reaction solution at high concentrations which promote enzyme speed, accuracy, and processivity.
- the detection volume Due to the small size of the ZMW, even at these high, biologically relevant concentrations, the detection volume is occupied by nucleotides only a small fraction of the time. In addition, visits to the detection volume are fast, lasting only a few microseconds, due to the very small distance that diffusion has to carry the nucleotides. The result is a very low background.
- 20080212960 entitled “Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources”, 20080206764, entitled “Flowcell system for single molecule detection”, 20080199932, entitled “Active surface coupled polymerases”, 20080199874, entitled “CONTROLLABLE STRAND SCISSION OF MINI CIRCLE DNA”, 20080176769, entitled “Articles having localized molecules disposed thereon and methods of producing same”, 20080176316, entitled “Mitigation of photodamage in analytical reactions”, 20080176241, entitled “Mitigation of photodamage in analytical reactions”, 20080165346, entitled “Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources”, 20080160531, entitled “Uniform surfaces for hybrid material substrates and methods for making and using same”, 20080157005, entitled “Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources”, 20080153100, entitled “Articles having localized molecules disposed thereon and methods of producing same”, 20080153095, entitled “
- DNA sequencing is achieved by parallel oligonucleotide extension (See, e.g., U.S. Pat. No. 5,750,341 to Macevicz et al., and U.S. Pat. No.
- single-stranded fragmented DNA is end-repaired to generate 5′-phosphorylated blunt ends, followed by Klenow-mediated addition of a single A base to the 3′ end of the fragments.
- A-addition facilitates addition of T-overhang adaptor oligonucleotides, which are subsequently used to capture the template-adaptor molecules on the surface of a flow cell that is studded with oligonucleotide anchors.
- the anchor is used as a PCR primer, but because of the length of the template and its proximity to other nearby anchor oligonucleotides, extension by PCR results in the “arching over” of the molecule to hybridize with an adjacent anchor oligonucleotide to form a bridge structure on the surface of the flow cell.
- These loops of DNA are denatured and cleaved. Forward strands are then sequenced with reversible dye terminators.
- the sequence of incorporated nucleotides is determined by detection of post-incorporation fluorescence, with each fluor and block removed prior to the next cycle of dNTP addition. Sequence read length ranges from 36 nucleotides to over 50 nucleotides, with overall output exceeding 1 billion nucleotide pairs per analytical run.
- the most recent generation of Lasergen's dNTP protected analogues have a DT50 of approximately 750 msec (time required to deblock 50% of the molecules).
- the DT50 for three Lasergen dNTP analogues is shown in FIG. 1 .
- a t1/2 of 750 msec gives the decay curve in solution shown in FIG. 2 .
- a deprotection time of 4.6 seconds is required to deprotect 98.5% of the dNTP's (as shown in FIG. 3 ). This is required for every cycle using the standard “wash” approach, where unincorporated nucleotides are removed before deprotection.
- FIG. 1 The DT50 for three Lasergen dNTP analogues is shown in FIG. 1 .
- a t1/2 of 750 msec gives the decay curve in solution shown in FIG. 2 .
- a deprotection time of 4.6 seconds is required to deprotect 98.5% of the dNTP's (as shown in FIG.
- a rapid light pulse of 100 msec, for example is used to eliminate the problem of spurious base addition. Therefore, a fast light pulse, followed by a longer read time (for single molecules) generally limits base extension to single base only, thereby increasing sequencing accuracy.
- FIG. 5 uses an arbitrary detection time of 5 seconds for demonstration purposes only. Under this scenario, the kinetics of deprotection is derived from the standard decay curve. This results in the deprotection ratio shown in FIG. 6 .
- the base addition mechanism for this example, can be modeled using the Binomial Expansion equation:
- X fraction of molecules remaining blocked after 100 msec light pulse
- Y fraction of molecules deprotected after 100 msec light pulse
- N cycle number.
- the strobe flashes are intermixed with a 5-sec detection step. Producing multiple strobe flashes serially (before a detection read) was not done since this would not give any advantage over a long deprotect time. It is generally assumed for this example, that enough light makes it to the surface to mimic deprotection kinetics in solution. In this example, each light pulse will deprotect 8.8% of the molecules on the surface (from decay curve). Nucleotide addition occurs rapidly after deprotection.
- FIG. 8 ( a - i ) models 35 strobe cycles starting off with 10 6 target molecules on the surface.
- FIG. 8 a models cycle 0 , where there are 10 6 molecules on the surface waiting to be deblocked.
- cycle 1 shown in FIG. 8 b
- FIG. 8 c shows 5 cycles
- FIG. 8 d shows 10 cycles
- FIG. 8 e shows 15 cycles
- FIG. 8 f shows 20 cycles.
- FIG. 8 f shows that a normal distribution is starting to appear.
- FIG. 8 f shows that a normal distribution is starting to appear. As shown in FIG.
- FIG. 8 g 25 cycles
- the distribution curve is slowly moving to the right, while the distribution itself is slowly diminishing and becoming more spread out, with each successive cycle.
- FIG. 8 h shows the distribution after 30 cycles.
- FIG. 8 i 35 cycles
- the normal distribution continues to diminish and spread out, much like Poisson distribution at high copy number.
- the 35 cycles in FIG. 8 i represents about 3 minutes of sequencing run time.
- FIG. 9 shows the results of extending cycle number out to 400 cycles (still using 100 mSec strobes of deblocking light), where each curve represents the distribution after 10 strobe cycles.
- FIG. 10 shows the results of extending the cycle number out to 400 cycles using 50 mSec strobes, where 4.4% of available photolabile bases are deblocked.
- FIG. 11 shows the distribution expected if 50% of the molecules deblock during the 100 msec pulse (as opposed to 8.8%). Each curve represents the distribution after 10 strobe cycles.
- the use of short pulses of deprotecting light is beneficially used to detect homopolymers.
- the capability to detect homopolymers depends on the ability to detect small changes in statistical sampling. Homopolymers reduce the number of base changes during each detection step.
- a mathematical model for detecting homopolymers is shown in FIG. 12 .
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Optics & Photonics (AREA)
- Clinical Laboratory Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Provided herein are systems and methods for nucleic acid sequencing by synthesis in a plurality of wells using detectably labeled chain terminating nucleotides with photolabile blocking groups and pulses of photocleaving light. In certain embodiments, the systems and methods provides a plurality of deblock-scan cycles comprising an initial deblock time period followed by a scanning light period, wherein at least one of the following occurs in each deblock-scan cycle: 1) the deblock time period is shorter than the scan time period; 2) the deblock time period is only long enough to deblock the photolabile groups that are part of a primer in less than all of the plurality of wells; or 3) the deblock time period is between 25 and 150 mSec and the scan time is at least 200 mSec. Such shorter deblock time periods help prevent the addition of more than one nucleotide to the primer prior to scanning (e.g., accuracy is enhanced).
Description
- The present Application is a continuation of U.S. application Ser. No. 15/512,441 filed Mar. 17, 2017, which is a national phase application under 35 U.S.C. § 371 of PCT International Application No. PCT/US2015/050376 filed on Sep. 16, 2015, which claims priority to U.S. Provisional Application Ser. No. 62/051,705 filed Sep. 17, 2014, the entirety of which is incorporated by reference herein.
- Provided herein are systems and methods for nucleic acid sequencing by synthesis in a plurality of wells using detectably labeled chain terminating nucleotides with photolabile blocking groups and pulses of photocleaving light. In certain embodiments, the systems and methods provide a plurality of deblock-scan cycles comprising an initial deblock time period followed by a scanning light period, wherein at least one of the following occurs in each deblock-scan cycle: 1) the deblock time period is shorter than the scan time period; 2) the deblock time period is only long enough to deblock the photolabile groups that are part of a primer in less than all of the plurality of wells; or 3) the deblock time period is between 25 and 150 mSec and the scan time is at least 200 mSec. Such shorter deblock time periods help prevent the addition of more than one nucleotide to the primer prior to scanning (e.g., accuracy is enhanced).
- In sequencing by synthesis with detectably labeled nucleotides with photolabile blocking groups, the time period needed for complete deblocking is relatively long, while the time period of nucleotide incorporation is relatively fast. As a result of the relatively long-deblocking time, additional nucleotides may be incorporated onto the end of the primer sequence before they can be scanned and detected. Therefore, the accuracy of the sequencing reaction may be compromised.
- Provided herein are systems and methods for nucleic acid sequencing by synthesis in a plurality of wells using detectably labeled chain terminating nucleotides with photolabile blocking groups and pulses of photocleaving light. In certain embodiments, the systems and methods provide a plurality of deblock-scan cycles comprising an initial deblock time period followed by a scanning light period, wherein at least one of the following occurs in each deblock-scan cycle: 1) the deblock time period is shorter than the scan time period; 2) the deblock time period is only long enough to deblock the photolabile groups that are part of a primer in less than all of the plurality of wells; or 3) the deblock time period is between 25 and 150 mSec and the scan time is at least 200 mSec. Such shorter deblock time periods, in some embodiments, help prevent the addition of more than one nucleotide to the primer prior to scanning (e.g., accuracy is enhanced).
- In some embodiments, provided herein are systems for photocleaving and scanning nucleotide analogs comprising: a) a substrate comprising a plurality of wells which each contain, or are configured to contain, a reaction mixture comprising a template nucleic acid, a polymerase, a primer hybridized to the template, and a first nucleotide analog, wherein the primer comprises a 3′ terminal nucleotide analog with a photolabile blocking group that terminates chain extension, and wherein the first nucleotide analog comprises: i) a first detectable moiety, and ii) a photolabile blocking group that terminates chain extension; and b) a light system component comprising: i) a light source in optical communication with the plurality of wells which is configured to provide: A) photocleaving light input that cleaves the photolabile blocking group when it is part of the primer; and B) scanning input light that provides an optical signal from the first detectable moiety after the first nucleotide analog is added to the primer by the polymerase; and ii) a light control component that activates the light source such that a plurality of deblock-scan cycles are generated, wherein each of the deblock-scan cycles comprise an initial deblock time period where at least a part of the photocleaving light input is passed into the plurality of wells, and a following scan time period where at least part of the scanning light input is passed into the plurality of wells, and wherein at least one of the following occurs in each of the deblock-scan cycles: A) the deblock time period is shorter than the scan time period; B) the deblock time period is only long enough to deblock the photolabile blocking groups that are part of the primer in less than all of the plurality of wells; and C) the deblock time period is between 25 and 150 mSec and the scan time is at least 200 mSec.
- In certain embodiments, provided herein are systems comprising a light component, wherein the light component is configured to optically interface with a substrate component, wherein the substrate component comprises a plurality of wells, wherein each well contains, or is configured to contain, a reaction mixture comprising a template nucleic acid, a polymerase, a primer hybridized to the template, and a first nucleotide analog, wherein the primer comprises a 3′ terminal nucleotide analog with a photolabile blocking group that terminates extension, and wherein the first nucleotide analog comprises: i) a detectable moiety, and ii) a photolabile blocking group that terminates chain extension; and wherein the light component comprises: a) a light source in optical communication with the plurality of wells that provides: A) photocleaving light input that cleaves the photolabile blocking group when it is part of the primer; and B) scanning input light that produces an optical signal from the first detectable moiety after the first nucleotide analog is added to the primer by the polymerase; and b) a light control component that activates the light source such that a plurality of deblock-scan cycles are generated, wherein each of the deblock-scan cycles comprise an initial deblock time period where at least part of the photocleaving light input is passed into the plurality of wells, and a following scan time period where at least part of the scanning light input is passed into the plurality of wells, and wherein at least one of the following occurs in each of the deblock-scan cycles: i) the deblock time period is shorter than the scan time period; ii) the deblock time period is only long enough to deblock the photolabile blocking groups that are part of the primer in less than all of the plurality of wells; and iii) the deblock time period is between 25 and 150 mSec and the scan time is at least 200 mSec.
- In particular embodiments, provided herein are methods for photocleaving and detecting nucleotide analogs using a system comprising: i) a substrate comprising a plurality of wells, wherein each well contains a reaction mixture comprising a template nucleic acid, a polymerase, a primer hybridized to the template, and a first nucleotide analog, wherein the primer comprises a 3′ terminal nucleotide analog with a photolabile blocking group that terminates chain extension, and wherein the first nucleotide analog comprises: i) a first detectable moiety, and ii) a photolabile blocking group that terminates chain extension; and ii) a light system component comprising: A) a light source in optical communication with the plurality of wells, wherein the light source provides: I) photocleaving light input; and II) scanning light input; B) a light control component that activates the light source such that a plurality of deblock-scan cycles are generated which comprise: I) an initial deblock time period where at least a portion of the photocleaving light input is passed into the wells, and II) a following scan time period where at least a portion of the scanning light input is passed into the wells, iii) a detector component in optical communication with the plurality of optical sensing wells, wherein the method comprises; and b) activating the light control component such that the light source component provides a plurality of the deblock-scan cycles which delock the photolabile blocking groups, when the photolabile blocking groups are part of the primer, in at least some of the wells and generates an optical signal from the detectable moiety in the plurality of wells after the first nucleotide analog is added to the primer by the polymerase, wherein at least one of the following occurs in each of the deblock-scan cycles: A) the deblock time period is shorter than the scan time period; B) the deblock time period is only long enough to deblock the photolabile blocking groups that are part of the primer in less than all of the plurality of wells; and C) the deblock time period is between 25 and 150 mSec and the scan time is at least 200 mSec; and c) detecting the optical signal from detectable moiety generated during each of the plurality of deblock-scan cycles in the plurality of wells with the detector component.
- In some embodiments, provided herein are systems comprising a light component, wherein the light component is configured to optically interface with a substrate component, wherein the substrate component comprises a plurality of wells (e.g., optical sensing wells), wherein each of the wells is sized to provide an internal waveguide (e.g., a zero mode waveguide) and/or is optically coupled to an external waveguide (e.g., a planar waveguide), wherein each well contains, or is configured to contain, a reaction mixture comprising a template nucleic acid, a polymerase, a primer hybridized to the template, and a first nucleotide analog, wherein the primer comprises a 3′ terminal nucleotide analog with a photolabile blocking group that terminates extension, and wherein the first nucleotide analog comprises: i) a detectable moiety, and ii) a photolabile blocking group that terminates chain extension; and wherein the light component comprises: a) a light source in optical communication with the internal and/or external waveguides, wherein the light source is configured to provide: A) photocleaving light input that, when passed into the internal or external waveguides, generates a first electromagnetic wave (e.g., evanescent wave) in the optical sensing wells that is capable of cleaving the photolabile blocking groups when they are part of the primer; and B) scanning input light that, when passed into the internal or external waveguides, generates a second electromagnetic wave (e.g., evanescent wave) in the optical sensing wells that is capable of producing an optical signal from the detectable moiety after the first nucleotide analog is added to the primer; and b) a light control component configured to activate the light source such that a plurality of deblock-scan cycles are generated, wherein each of the deblock-scan cycles comprise an initial deblock time period where the photocleaving light input is passed into the internal and/or external waveguides, and a following scan time period where the scanning light input is passed into the internal and/or external waveguides, and wherein at least one of the following occurs in each of the deblock-scan cycles: A) the deblock time period is shorter than the scan time period; B) the deblock time period is only long enough to deblock the photolabile blocking groups that are part of the primer in less than all of the plurality of optical sensing wells; and C) the deblock time period is between 25 and 150 mSec and the scan time is at least 200 mSec.
- In certain embodiments, provided herein are systems for system for photocleaving and scanning nucleotide analogs comprising: a) a substrate comprising a plurality of optical sensing wells, wherein each of the optical sensing wells is sized to provide an internal waveguide and/or is optically coupled to an external waveguide, wherein each optical sensing well contains, or is configured to contain, a reaction mixture comprising a template nucleic acid, a polymerase, a primer hybridized to the template, and a first nucleotide analog, wherein the primer comprises a 3′ terminal nucleotide analog with a photolabile blocking group that terminates chain extension, and wherein the first nucleotide analog comprises: i) a first detectable moiety, and ii) a photolabile blocking group that terminates chain extension; and b) a light system component comprising: i) a light source in optical communication with the internal and/or external waveguides, wherein the light source is configured to provide: A) photocleaving light input that, when passed into the internal or external waveguides, generates a first electromagnetic wave (e.g., evanescent wave) in the optical sensing wells that is capable of cleaving the photolabile blocking group when it is part of the primer; and B) scanning input light that, when passed into the internal or external waveguides, generates a second electromagnetic wave (e.g., evanescent wave) in the optical sensing wells that is capable of producing an optical signal from the first detectable moiety after the first nucleotide analog is added to the primer by the polymerase; and ii) a light control component configured to activate the light source such that a plurality of deblock-scan cycles are generated, wherein each of the deblock-scan cycles comprise an initial deblock time period where the photocleaving light input is passed into the internal and/or external waveguides, and a following scan time period where the scanning light input is passed into the internal and/or external waveguides, and wherein at least one of the following occurs in each of the deblock-scan cycles: A) the deblock time period is shorter than the scan time period; B) the deblock time period is only long enough to deblock the photolabile blocking groups that are part of the primer in less than all of the plurality of optical sensing wells; and C) the deblock time period is between 25 and 150 mSec and the scan time is at least 200 mSec.
- In particular embodiments, provided herein are methods for photocleaving and detecting nucleotide analogs using a system comprising: i) a substrate comprising a plurality of optical sensing wells, wherein each of the optical sensing wells is sized to provide an internal waveguide and/or is optically coupled to an external waveguide, wherein each optical sensing well contains a reaction mixture comprising a template nucleic acid, a polymerase, a primer hybridized to the template, and a first nucleotide analog, wherein the primer comprises a 3′ terminal nucleotide analog with a photolabile blocking group that terminates chain extension, and wherein the first nucleotide analog comprises: i) a first detectable moiety, and ii) a photolabile blocking group that terminates chain extension; and ii) a light system component comprising: A) a light source in optical communication with the internal and/or external waveguides, wherein the light source provides: I) photocleaving light input that generates a first electromagnetic wave in the optical sensing wells when passed into the internal or external waveguides; and II) scanning input light that generates a second electromagnetic wave in the optical sensing wells when passed into the internal or external waveguides; B) a light control component configured to activate the light source such that a plurality of deblock-scan cycles are generated which comprise: I) an initial deblock time period where the photocleaving light input is passed into the internal and/or external waveguides, and II) a following scan time period where the scanning light input is passed into the internal and/or external waveguides, iii) a detector component in optical communication with the plurality of optical sensing wells, wherein the method comprises: activating the light control component such that the light source component provides a plurality of the deblock-scan cycles which delock the photolabile blocking groups, when they are part of the primer, in at least some of the optical sensing wells and generates an optical signal from the detectable moiety in the plurality of optical sensing wells after the first nucleotide analog is added to the primer by the polymerase, wherein at least one of the following occurs in each of the deblock-scan cycles: A) the deblock time period is shorter than the scan time period; B) the deblock time period is only long enough to deblock the photolabile blocking groups that are part of the primer in less than all of the plurality of optical sensing wells; and C) the deblock time period is between 25 and 150 mSec and the scan time is at least 200 mSec; and c) detecting the optical signal from detectable moiety generated during each of the plurality of deblock-scan cycles in the plurality of optical sensing wells with the detector component.
- In particular embodiments, the detecting provides sequence information for at least a portion of the template nucleic acid in at least some of the plurality of wells (e.g., the identity of 5 bases . . . 10 bases . . . or more; or the complete sequence of the template). In certain embodiments, the light control component comprises a user interface, and wherein the activating is performed by a user through the user interface. In further embodiments, the user interface comprises a computer keyboard and/or computer mouse. In particular embodiments, the methods are performed without any washing step (e.g., single reaction mixture in well during entire sequence by synthesis reaction).
- In some embodiments, the systems further comprise c) a detector component in optical communication with the plurality of wells which is capable of detecting the optical signal from the plurality of wells. In certain embodiments, the system further comprises a filter, where said optical signal passes through said filter prior to being detected by said detector. In certain embodiments, the light control component comprises a computer processor and a computer program embedded within the computer processor, wherein the computer program that controls the light source such that the plurality of deblock-scan cycles are generated.
- In particular embodiments, the substrate is composed of a material selected from the group consisting of: transparent glass, transparent plastic, silicon-titanium oxide, titanium oxide, tantalum oxide, niobium oxide, hafnium oxide, aluminum oxide, zirconium oxide, silicon nitride, aluminum nitride, titanium nitride, polycarbonate (PC), PMMA, or Su8. In other embodiments, the plurality of wells comprises at least 5 wells (e.g., at least 5 . . . 25 . . . 100 . . . 250 . . . 500 . . . 1000 . . . 2000 . . . 4000 . . . 8000 . . . 50,000 . . . or more).
- In particular embodiments, the plurality of wells are sized to provide an internal waveguide (e.g., an internal waveguide at the bottom of said wells). In certain embodiments, each of the plurality of wells comprises a zero-mode waveguide. In particular embodiments, the systems further comprise one or a plurality of external waveguides (e.g., an external waveguide for each of the plurality of optically sensing wells). In particular embodiments, the plurality of wells have a volume between 200 nanoliters and 10 zeptoliters. In further embodiments, the plurality of wells are optically coupled to an external waveguide. In additional embodiments, each of the wells contains the reaction mixture.
- In certain embodiments, the template nucleic acid in each of the plurality of wells is part of a sequencing library (e.g., human genomic sequencing library). In further embodiments, the photolabile blocking group that is part of the primer is the same as, or different from, the photolabile blocking group that is part of the first nucleotide analog. In other embodiments, the reaction mixture further comprises a second nucleotide analog (e.g., a second type of nucleotides analog) comprising a photolabile locking group and a second detectable moiety different from the first detectable moiety, wherein the first and second nucleotide analogs have different bases (e.g., selected from guanine, cytosine, adenine, and thymine). In other embodiments, the polymerase comprises a Phi29 polymerase or mutant thereof.
- In additional embodiments, the first detectable moiety comprises a fluorescent dye. In further embodiments, the photolabile blocking group is selected from the group consisting of: an o-nitrobenzyl blocking group, nitroveratryl, 1-pyrenylmethyl, 6-nitroveratryloxycarbonyl, dimethyldimethoxybenzyloxycarbonyl, 2-nitrobenzyloxycarbonyl, 5-bromo-7-nitroindolinyl, P-hydroxy-alpha-methyl-cinnamoyl, methyl, 6-nitroveratryloxycarbonyl, methyl-6-nitropiperonyloxycarbonyl, and 2-oxymethylene anthraquinone, dimethoxybenzyloxy carbonyl, 5-bromo-7-nitroindolinyl, o-hydroxy-alpha-methyl cinnamoyl, and 2-oxymethylene anthriquinone.
- In additional embodiments, the light source comprises a first light generating component configured to generate the photocleaving light input, and a second light generating component configured to generate the scanning light input. In other embodiments, the light source comprises a light generating component configured to alternately generate both the photocleaving light input and the scanning light input. In additional embodiments, the photocleaving light input has a wavelength between 300 nm and 2000 nm (e.g., 300 nm . . . 500 nm . . . 800 nm . . . 1200 nm . . . 1500 nm . . . and 2000 nm). In other embodiments, the scanning light input has a wavelength between 230 nm and 1000 nm (e.g., 230 nm 450 . . . 680 . . . 850 . . . and 1000 nm). In further embodiments, the photocleaving light input has a wavelength different than that of the scanning light input wavelength.
- In certain embodiments, the external waveguide comprises one or more planar waveguides. In further embodiments, the plurality of wells are optically coupled to an external waveguide, wherein the external waveguide is either one waveguide in optical communication with all of the plurality of wells, or wherein the external waveguide is a plurality of waveguides, one for each of the plurality of wells.
- In additional embodiments, the first and/or second electromagnetic waves comprises an evanescent wave or a traveling field wave. In further embodiments, the light control component comprises a user interface that allows a user to activate the light source. In additional embodiments, the plurality of deblock-scan cycles is at least five deblock-scan cycles (e.g., at least 5 . . . 10 . . . 15 . . . 25 . . . 100 . . . 1000 or more). In further embodiments, the deblock time period is shorter than the scan time period. In additional embodiments, the deblock time period is 5% shorter than the scan time period (e.g., 5% . . . 15% . . . 25% . . . 50% . . . 68% . . . 75% . . . 90% . . . 95% . . . or 99% shorter).
- In particular embodiments, the deblock time period is only long enough to deblock the photolabile blocking groups that are part of the primer in less than all of the plurality of wells. In further embodiments, the deblock time period is only long enough to deblock the photolabile blocking groups that are part of the primer in about 7-12 percent, or about 12-25%, or about 25-55% of the plurality of wells. In certain embodiments, the deblock time period is between 15 and 150 mSec (e.g., 15 . . . 25 . . . 50 . . . 75 . . . 100 . . . 125 . . . and 150 mSec) and the scan time is at least 200 mSec (e.g., at least 200 mSec . . . 500 mSec . . . 750 mSec . . . 1 second . . . 1.5 seconds . . . 2 seconds . . . 5 seconds . . . 10 seconds . . . or more).
-
FIG. 1 shows the DT50 (time required to deblock 50% of the molecules) for a number of Lasergen dNTP analogues. -
FIG. 2 shows a decay curve for a blocked base ((S)-t-butyl-5-methoxy-2-nitrobenzyl dNTP) with a t1/2 of 750 mSec. -
FIG. 3 shows, based on the curve inFIG. 2 , a deprotection time of 4.6 seconds is required to deprotect 98.5% of the dNTP's. -
FIG. 4 shows that a rapid light pulse of 100 msec, for example, could then be used to eliminate the problem of spurious base addition. -
FIG. 5 shows that, given the extension rate of standard DNA polymerase on a surface is approximately 5 bases/sec, it would be expected that the new base incorporated after the 100 msec pulse would be relatively rapid. -
FIG. 6 shows that the kinetics of deprotection can be derived from the standard decay curve, resulting in the deprotection ratio shown in this figure. -
FIG. 7 shows three strobe cycles, using 106 molecules in the binomial expansion model described in Example 1 below. -
FIGS. 8a- i model 35 strobe cycles starting off with 106 target molecules on a surface as described in Example 1.FIG. 8a models cycle 0, where there are 106 molecules on the surface waiting to be deblocked. At cycle 1 (shown inFIG. 8b ), 8.8% of the 106 molecules on the surface will be deprotected and extended (darker/blue bar), while 91.2% will remain blocked (lighter bar).FIG. 8c shows 5 cycles,FIG. 8d shows 10 cycles,FIG. 8e shows 15 cycles, andFIG. 8f shows 20 cycles.FIG. 8f shows that a normal distribution is starting to appear. As shown inFIG. 8g (25 cycles), the distribution curve is slowly moving to the right, while the distribution itself is slowly diminishing and becoming more spread out, with each successive cycle.FIG. 8h shows the distribution after 30 cycles. As shown inFIG. 8i (35 cycles), the normal distribution continues to diminish and spread out, much like Poisson distribution at high copy number. The 35 cycles inFIG. 8i represents about 3 minutes of sequencing run time. -
FIG. 9 shows the results of extending cycle number out to 400 cycles (still using 100 mSec strobes of deblocking light), where each curve represents the distribution after 10 strobe cycles. -
FIG. 10 shows the results of extending the cycle number out to 400 cycles using 50 mSec strobes, where 4.4% of available photolabile bases are deblocked. -
FIG. 11 shows the distribution expected if 50% of the molecules deblock during the 100 msec pulse (as opposed to 8.8%). Each curve represents the distribution after 10 strobe cycles. -
FIG. 12 shows a mathematical model for detecting homopolymers by short pulses of deprotecting light. - Provided herein are systems and methods for nucleic acid sequencing by synthesis in a plurality of wells using detectably labeled chain terminating nucleotides with photolabile blocking groups and pulses of photocleaving light. In certain embodiments, the systems and methods provides a plurality of deblock-scan cycles comprising an initial deblock time period followed by a scanning light period, wherein at least one of the following occurs in each deblock-scan cycle: 1) the deblock time period is shorter than the scan time period; 2) the deblock time period is only long enough to deblock the photolabile groups that are part of a primer in less than all of the plurality of wells; or 3) the deblock time period is between 25 and 150 mSec and the scan time is at least 200 mSec. Such shorter deblock time periods help prevent the addition of more than one nucleotide to the primer prior to scanning (e.g., accuracy is enhanced).
- The present description is not limited to the type of sequencing approach that is used with the photolabile blocked nucleotides and deblock-scan cycles provided herein. In certain embodiments, sequence by synthesis methods are employed. Exemplary sequencing methods are detailed further below. In certain embodiments, the deblock-scan cycles described herein are used with sequencing methodologies that employ Zero-mode waveguides (e.g., as produced by Pacific Biosciences). In an exemplary embodiments, a sequencing by synthesis approach using a zero mode wave guide ZMWG and a photo-deblockable nucleotide is used to enable a single fluid sequencing by synthesis process. The ZMWG is used, for example, to both detect the detectably (e.g., flourescently) labeled nucleotide in the acceptor site of a polymerase and to selectively deblock this nucleotide while not deblocking the nucleotides in the reaction buffer that are outside the illumination field of the ZMWGs. Such an approach allows single molecule sequencing by synthesis. The challenge is the time domains for de-blocking (relatively slow) and nucleotide incorporation (relatively fast) may not be compatible for accurate sequencing as additional nucleotides may be incorporated during the relatively longer de-blocking step.
- The present description overcomes such issues with timing and accuracy. For example, the deblock-scan cycles described herein breakup the de-blocking time into pulses followed by reads. For example if it take 5 seconds to efficiently de-block 99% of the nucleotides in the polymerase and 200 mSec to incorporate a nucleotide, then one pulse (with photocleaving light) for a brief period of time, for example 50mSec, and then read the base (using scanning light and a detector). In this way, changes in the nucleotide sequence are detected and the de-blocking time is, for example, significantly shorter than the incorporation time. In addition, in certain embodiments, one detects the molecules that are still waiting to accept the next nucleotide as being without a labeled nucleotide to enable accurate sequencing of homopolymeric sequences. In this regard, the systems and methods described herein allows a single fluid (e.g., no washing required) single molecule sequencing by synthesis when the time domains for photo de-blocking and nucleotide incorporation are not compatible.
- As indicated above, the present description is not limited to any particular sequencing technology that can employ photolabile blocked nucleotides and the deblock-scan cycles described herein. In certain embodiments, the sequencing by synthesis methods employ waveguides (e.g., planar, zero-mode waveguides, etc.). In certain embodiments, such methods are described in the following publications: U.S. Pat. Nos. 7,476,504; 8,747,751; Pat. Pub. 20110306143; and Pat. Pub. 20120156100; all of which are herein incorporated by reference in their entireties. These four publications are specifically incorporated by reference, including the figures and descriptions of the figures, as if fully set forth herein.
- Again, the present description is not limited to any particular sequencing technology that can employ photolabile blocked nucleotides and the deblock-scan cycles described herein. One real-time single molecule sequencing system that is employed is that developed by Pacific Biosciences that employs Zero Mode Wave Guides (ZMWs), and described in Voelkerding et al., Clinical Chem., 55: 641-658, 2009; MacLean et al., Nature Rev. Microbiol., 7: 287-296; U.S. Pat. Nos. 7,170,050; 7,302,146; 7,313,308; 7,476,503; all of which are herein incorporated by reference. In general, such methods utilizes reaction wells 50-100 nm in diameter and encompassing a reaction volume of approximately 20 zeptoliters (10×10−21 L). Sequencing reactions are performed using immobilized template, modified phi29 DNA polymerase, and high local concentrations of fluorescently labeled dNTPs. High local concentrations and continuous reaction conditions allow incorporation events to be captured in real time by fluor signal detection using laser excitation, an optical waveguide, and a CCD camera. With this technology, DNA sequencing is generally performed on SMRT chips, each containing thousands of zero-mode waveguides (ZMWs). A ZMW is a hole/well, tens of nanometers in diameter, fabricated in a 100 nm metal film deposited on a silicon dioxide substrate. Each ZMW becomes a nanophotonic visualization chamber providing a detection volume of just 20 zeptoliters (10-21 liters). At this volume, the activity of a single molecule is detected amongst a background of thousands of labeled nucleotides. The ZMW provides a window for watching DNA polymerase as it performs sequencing by synthesis. Within each chamber, a single DNA polymerase molecule is attached to the bottom surface such that it permanently resides within the detection volume. Phospholinked nucleotides (would be blocked with photolabile blocking groups for the systems and methods described herein), each type labeled with a different colored fluorophore, are then introduced into the reaction solution at high concentrations which promote enzyme speed, accuracy, and processivity. Due to the small size of the ZMW, even at these high, biologically relevant concentrations, the detection volume is occupied by nucleotides only a small fraction of the time. In addition, visits to the detection volume are fast, lasting only a few microseconds, due to the very small distance that diffusion has to carry the nucleotides. The result is a very low background.
- Other processes and systems that may be adapted to employ photolabile blocked nucleotides the deblock-scan cycles provides herein are described in, for example, U.S. Pat. No. 7,405,281, entitled “Fluorescent nucleotide analogs and uses therefor;” U.S. Pat. No. 7,315,019, entitled “Arrays of optical confinements and uses thereof;” U.S. Par. No. 7,313,308, entitled “Optical analysis of molecules,” U.S. Pat. No. 7,302,146, entitled “Apparatus and method for analysis of molecules” , and U.S. Pat. No. 7,170,050, entitled “Apparatus and methods for optical analysis of molecules,” U.S. Patent Publications Nos. 20080212960, entitled “Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources”, 20080206764, entitled “Flowcell system for single molecule detection”, 20080199932, entitled “Active surface coupled polymerases”, 20080199874, entitled “CONTROLLABLE STRAND SCISSION OF MINI CIRCLE DNA”, 20080176769, entitled “Articles having localized molecules disposed thereon and methods of producing same”, 20080176316, entitled “Mitigation of photodamage in analytical reactions”, 20080176241, entitled “Mitigation of photodamage in analytical reactions”, 20080165346, entitled “Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources”, 20080160531, entitled “Uniform surfaces for hybrid material substrates and methods for making and using same”, 20080157005, entitled “Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources”, 20080153100, entitled “Articles having localized molecules disposed thereon and methods of producing same”, 20080153095, entitled “CHARGE SWITCH NUCLEOTIDES”, 20080152281, entitled “Substrates, systems and methods for analyzing materials”, 20080152280, entitled “Substrates, systems and methods for analyzing materials”, 20080145278, entitled “Uniform surfaces for hybrid material substrates and methods for making and using same”, 20080128627, entitled “SUBSTRATES, SYSTEMS AND METHODS FOR ANALYZING MATERIALS”, 20080108082, entitled “Polymerase enzymes and reagents for enhanced nucleic acid sequencing”, 20080095488, entitled “SUBSTRATES FOR PERFORMING ANALYTICAL REACTIONS”, 20080080059, entitled “MODULAR OPTICAL COMPONENTS AND SYSTEMS INCORPORATING SAME”, 20080050747, entitled “Articles having localized molecules disposed thereon and methods of producing and using same”, 20080032301, entitled “Articles having localized molecules disposed thereon and methods of producing same”, 20080030628, entitled “Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources”, 20080009007, entitled “CONTROLLED INITIATION OF PRIMER EXTENSION”, 20070238679, entitled “Articles having localized molecules disposed thereon and methods of producing same”, 20070231804, entitled “Methods, systems and compositions for monitoring enzyme activity and applications thereof, 20070206187, entitled “Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources”, 2007019684 6, entitled “Polymerases for nucleotide analogue incorporation”, 20070188750, entitled “Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources”, 20070161017, entitled “MITIGATION OF PHOTODAMAGE IN ANALYTICAL REACTIONS”, 20070141598, entitled “Nucleotide Compositions and Uses Thereof, 20070134128, entitled “Uniform surfaces for hybrid material substrate and methods for making and using same”, 20070128133, entitled “Mitigation of photodamage in analytical reactions”, 20070077564, entitled “Reactive surfaces, substrates and methods of producing same”, 20070072196, entitled “Fluorescent nucleotide analogs and uses therefore”, and 20070036511, entitled “Methods and systems for monitoring multiple optical signals from a single source”, and Korlach et at (2008) “Selective aluminum passivation for targeted immobilization of single DNA polymerase molecules in zero-mode waveguide nanostructures” Proc. Natl. Acad. Sci. U.S.A. 105(4): 11761181—all of which are herein incorporated by reference in their entireties.
- Other sequencing methodologies that may be adapted to employ the photolabile blocked nucleotides and deblock-scan cycles described herein are known in the art, including fluorescence-based sequencing methodologies (See, e.g., Birren et al., Genome Analysis: Analyzing DNA, 1, Cold Spring Harbor, N.Y.; herein incorporated by reference in its entirety). In some embodiments, automated sequencing techniques understood in that art are utilized. In some embodiments, DNA sequencing is achieved by parallel oligonucleotide extension (See, e.g., U.S. Pat. No. 5,750,341 to Macevicz et al., and U.S. Pat. No. 6,306,597 to Macevicz et al., both of which are herein incorporated by reference in their entireties). Additional examples of sequencing techniques include the Church polony technology (Mitra et al., 2003, Analytical Biochemistry 320, 55-65; Shendure et al., 2005 Science 309, 1728-1732; U.S. Pat. Nos. 6,432,360, 6,485,944, 6,511,803; herein incorporated by reference in their entireties) the 454 picotiter pyrosequencing technology (Margulies et al., 2005 Nature 437, 376-380; US 20050130173; herein incorporated by reference in their entireties), the Solexa single base addition technology (Bennett et al., 2005, Pharmacogenomics, 6, 373-382; U.S. Pat. Nos. 6,787,308; 6,833,246; herein incorporated by reference in their entireties), the Lynx massively parallel signature sequencing technology (Brenner et al. (2000). Nat. Biotechnol. 18:630-634; U.S. Pat. Nos. 5,695,934; 5,714,330; herein incorporated by reference in their entireties) and the Adessi PCR colony technology (Adessi et al. (2000). Nucleic Acid Res. 28, E87; WO 00018957; herein incorporated by reference in its entirety).
- Another sequencing methodology that may be adapted to employ the photolabile blocked nucleotides and deblock-scan cycles described herein is the Solexa/Illumina platform. In the Solexa/Illumina platform (Voelkerding et al., Clinical Chem., 55: 641-658, 2009; MacLean et al., Nature Rev. Microbiol., 7: 287-296; U.S. Pat. Nos. 6,833,246; 7,115,400; 6,969,488; each herein incorporated by reference in its entirety), sequencing data are produced in the form of shorter-length reads. In this method, single-stranded fragmented DNA is end-repaired to generate 5′-phosphorylated blunt ends, followed by Klenow-mediated addition of a single A base to the 3′ end of the fragments. A-addition facilitates addition of T-overhang adaptor oligonucleotides, which are subsequently used to capture the template-adaptor molecules on the surface of a flow cell that is studded with oligonucleotide anchors. The anchor is used as a PCR primer, but because of the length of the template and its proximity to other nearby anchor oligonucleotides, extension by PCR results in the “arching over” of the molecule to hybridize with an adjacent anchor oligonucleotide to form a bridge structure on the surface of the flow cell. These loops of DNA are denatured and cleaved. Forward strands are then sequenced with reversible dye terminators. The sequence of incorporated nucleotides is determined by detection of post-incorporation fluorescence, with each fluor and block removed prior to the next cycle of dNTP addition. Sequence read length ranges from 36 nucleotides to over 50 nucleotides, with overall output exceeding 1 billion nucleotide pairs per analytical run.
- The most recent generation of Lasergen's dNTP protected analogues have a DT50 of approximately 750 msec (time required to deblock 50% of the molecules). The DT50 for three Lasergen dNTP analogues is shown in
FIG. 1 . A t1/2 of 750 msec gives the decay curve in solution shown inFIG. 2 . Based on this curve, a deprotection time of 4.6 seconds is required to deprotect 98.5% of the dNTP's (as shown inFIG. 3 ). This is required for every cycle using the standard “wash” approach, where unincorporated nucleotides are removed before deprotection. As shown inFIG. 4 , a rapid light pulse of 100 msec, for example, is used to eliminate the problem of spurious base addition. Therefore, a fast light pulse, followed by a longer read time (for single molecules) generally limits base extension to single base only, thereby increasing sequencing accuracy. - Given the extension rate of standard DNA polymerase on a surface is approximately 5 bases/sec, the new base incorporated after the 100 msec pulse is relatively rapid as shown in the time sequence in
FIG. 5 .FIG. 5 uses an arbitrary detection time of 5 seconds for demonstration purposes only. Under this scenario, the kinetics of deprotection is derived from the standard decay curve. This results in the deprotection ratio shown inFIG. 6 . - The base addition mechanism, for this example, can be modeled using the Binomial Expansion equation:
-
(X+Y)N - In this case, X=fraction of molecules remaining blocked after 100 msec light pulse; Y=fraction of molecules deprotected after 100 msec light pulse; and N=cycle number. For the present example, X=0.9121; and Y=0.0879. This ratio remains constant for each strobe cycle since a total of 106 molecules either have an existing base or a new base after each detection phase. Three strobe cycles, using 106 molecules in the binomial expansion model, are shown in
FIG. 7 . - In the present hypothetical example, the strobe flashes are intermixed with a 5-sec detection step. Producing multiple strobe flashes serially (before a detection read) was not done since this would not give any advantage over a long deprotect time. It is generally assumed for this example, that enough light makes it to the surface to mimic deprotection kinetics in solution. In this example, each light pulse will deprotect 8.8% of the molecules on the surface (from decay curve). Nucleotide addition occurs rapidly after deprotection.
-
FIG. 8 (a-i)models 35 strobe cycles starting off with 106 target molecules on the surface.FIG. 8a models cycle 0, where there are 106 molecules on the surface waiting to be deblocked. At cycle 1 (shown inFIG. 8b ), 8.8% of the 106 molecules on the surface are deprotected and extended (darker/blue bar), while 91.2% remain blocked (lighter bar).FIG. 8c shows 5 cycles,FIG. 8d shows 10 cycles,FIG. 8e shows 15 cycles, andFIG. 8f shows 20 cycles.FIG. 8f shows that a normal distribution is starting to appear. As shown inFIG. 8g (25 cycles), the distribution curve is slowly moving to the right, while the distribution itself is slowly diminishing and becoming more spread out, with each successive cycle.FIG. 8h shows the distribution after 30 cycles. As shown inFIG. 8i (35 cycles), the normal distribution continues to diminish and spread out, much like Poisson distribution at high copy number. The 35 cycles inFIG. 8i represents about 3 minutes of sequencing run time.FIG. 9 shows the results of extending cycle number out to 400 cycles (still using 100 mSec strobes of deblocking light), where each curve represents the distribution after 10 strobe cycles.FIG. 10 shows the results of extending the cycle number out to 400 cycles using 50 mSec strobes, where 4.4% of available photolabile bases are deblocked.FIG. 11 shows the distribution expected if 50% of the molecules deblock during the 100 msec pulse (as opposed to 8.8%). Each curve represents the distribution after 10 strobe cycles. - The use of short pulses of deprotecting light is beneficially used to detect homopolymers. The capability to detect homopolymers depends on the ability to detect small changes in statistical sampling. Homopolymers reduce the number of base changes during each detection step. A mathematical model for detecting homopolymers is shown in
FIG. 12 . - Although the invention has been described in connection with specific preferred embodiments, it should be understood that the invention as claimed should not be unduly limited to such specific embodiments. Various modification and variation of the described methods and compositions of the invention will be apparent to those skilled in the art without departing from the scope and spirit of the invention. Indeed, various modifications of the described modes for carrying out the invention understood by those skilled in the relevant fields are intended to be within the scope of the following claims. All publications and patents mentioned in the present application are herein incorporated by reference.
Claims (16)
1. A system for photocleaving and scanning nucleotide analogs comprising:
a) a substrate comprising a plurality of wells wherein each well contains a reaction mixture comprising a template nucleic acid, a polymerase, a primer hybridized to said template, and a first nucleotide analog, wherein said primer comprises a 3′ terminal nucleotide analog with a photolabile blocking group that terminates chain extension, and wherein said first nucleotide analog comprises:
i) a first detectable moiety, and ii) a photolabile blocking group that terminates chain extension; and
b) a light system component comprising:
i) a light source in optical communication with said plurality of wells which provides: A) photocleaving light input that cleaves said photolabile blocking group when it is part of said primer; and B) scanning input light that produces an optical signal from said first detectable moiety after said first nucleotide analog is added to said primer by said polymerase; and
ii) a light control component comprising a computer processor and a computer program wherein said computer program activates said light source such that a plurality of deblock-scan cycles are generated.
2. The system of claim 1 , further comprising c) a detector component in optical communication with said plurality of wells which detects said optical signal from said plurality of wells.
3. The system of claim 1 , wherein said substrate is composed of a material selected from the group consisting of: transparent glass, transparent plastic, silicon-titanium oxide, titanium oxide, tantalum oxide, niobium oxide, hafnium oxide, aluminum oxide, zirconium oxide, silicon nitride, aluminum nitride, titanium nitride, polycarbonate (PC), PMMA, and Su8.
4. The system of claim 1 , wherein said plurality of wells are sized to provide an internal waveguide.
5. The system of claim 4 , wherein each of said wells comprises a zero-mode waveguide.
6. The system of claim 1 , further comprising an external waveguide.
7. The system of claim 1 , wherein said wells are optically coupled to an external waveguide.
8. The system of claim 1 , wherein said template nucleic acid in each of said plurality of wells is part of a sequencing library.
9. The system of claim 1 , wherein said photolabile blocking group that is part of said primer is the same as the photolabile blocking group that is part of said first nucleotide analog.
10. The system of claim 1 , wherein said photolabile blocking group is selected from the group consisting of: an o-nitrobenzyl blocking group, nitroveratryl, 1-pyrenylmethyl, 6-nitroveratryloxycarbonyl, dimethyldimethoxybenzyloxycarbonyl, 2-nitrobenzyloxycarbonyl, methyl-6-nitropiperonyloxycarbonyl, dimethoxybenzyloxy carbonyl, 5-bromo-7-nitroindolinyl, o-hydroxy-alpha-methyl cinnamoyl, and 2-oxymethylene anthriquinone.
11. The system of claim 1 , wherein said light source comprises a first light generating component configured to generate said photocleaving light input, and a second light generating component configured to generate said scanning light input.
12. The system of claim 1 , wherein said plurality of wells are optically coupled to an external waveguide, wherein said external waveguide is either one waveguide in optical communication with all of said plurality of wells, or wherein said external waveguide is a plurality of waveguides, one for each of said plurality of wells.
13. The system of claim 1 , wherein said photolabile blocking group that is a part of said primer is different from the photolabile blocking group that is a part of said first nucleotide analog.
14. A method for photocleaving and detecting nucleotide analogs using a system comprising:
i) a substrate comprising a plurality of wells, wherein each well contains a reaction mixture comprising a template nucleic acid, a polymerase, a primer hybridized to said template, and a first nucleotide analog, wherein said primer comprises a 3′ terminal nucleotide analog with a photolabile blocking group that terminates chain extension, and wherein said first nucleotide analog comprises: i) a first detectable moiety, and ii) a photolabile blocking group that terminates chain extension; and
ii) a light system component comprising:
A) a light source in optical communication with said plurality of wells, wherein said light source provides: I) photocleaving light input; and II) scanning light input; and
B) a light control component comprising a computer processor and a computer program wherein said computer program activates said light source such that a plurality of deblock-scan cycles are generated, wherein each of said deblock-scan cycles comprises an initial deblock time period wherein at least a portion of said photocleaving light input is passed into said wells, and a following scan time period wherein at least a portion of said scanning light input is passed into said wells, and
iii) a detector component in optical communication with said plurality of wells,
wherein the method comprises:
a) activating said light control component such that said light source provides a plurality of said deblock-scan cycles which deblock said photolabile blocking groups when said photolabile groups are part of said primer in at least some of said wells, and generates an optical signal from said detectable moiety in said plurality of wells after said first nucleotide analog is added to said primer by said polymerase; and
b) detecting said optical signal from said detectable moiety generated during each of said plurality of deblock-scan cycles in said plurality of wells with said detector component.
15. A method for photocleaving and detecting nucleotide analogs using a system comprising:
i) a substrate comprising a plurality of optical sensing wells, wherein each of said optical sensing wells is sized to provide an internal waveguide and/or is optically coupled to an external waveguide, wherein each optical sensing well contains a reaction mixture comprising a template nucleic acid, a polymerase, a primer hybridized to said template, and a first nucleotide analog, wherein said primer comprises a 3′ terminal nucleotide analog with a photolabile blocking group that terminates chain extension, and wherein said first nucleotide analog comprises:
i) a first detectable moiety, and ii) a photolabile blocking group that terminates chain extension; and
ii) a light system component comprising:
A) a light source in optical communication with said internal and/or external waveguides, wherein said light source provides: I) photocleaving light input that generates a first electromagnetic wave in said optical sensing wells when passed into said internal or external waveguides; and II) scanning input light that generates a second electromagnetic wave in said optical sensing wells when passed into said internal or external waveguides; and
B) a light control component comprising a computer processor and a computer program wherein said computer program activates said light source such that a plurality of deblock-scan cycles are generated, wherein each of said deblock-scan cycles comprises an initial deblock time period wherein said photocleaving light input is passed into said internal and/or external waveguides, and a following scan time period wherein said scanning light input is passed into said internal and/or external waveguides, and
iii) a detector component in optical communication with said plurality of optical sensing wells;
wherein the method comprises:
a) activating said light control component such that said light source provides a plurality of said deblock-scan cycles which deblock said photolabile blocking groups when they are part of said primer in at least some of said optical sensing wells, and generates an optical signal from said detectable moiety in said plurality of optical sensing wells after said first nucleotide analog is added to said primer by said polymerase; and
b) detecting said optical signal from said detectable moiety generated during each of said plurality of deblock-scan cycles in said plurality of optical sensing wells with said detector component.
16. The method of claim 15 , wherein said detecting provides sequence information for at least a portion of said template nucleic acid in at least some of said plurality of optical sensing wells.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16/724,574 US20200123605A1 (en) | 2014-09-17 | 2019-12-23 | Sequencing by synthesis using pulse read optics |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462051705P | 2014-09-17 | 2014-09-17 | |
| PCT/US2015/050376 WO2016044391A1 (en) | 2014-09-17 | 2015-09-16 | Sequencing by synthesis using pulse read optics |
| US201715512441A | 2017-03-17 | 2017-03-17 | |
| US16/724,574 US20200123605A1 (en) | 2014-09-17 | 2019-12-23 | Sequencing by synthesis using pulse read optics |
Related Parent Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US15/512,441 Continuation US10550428B2 (en) | 2014-09-17 | 2015-09-16 | Sequencing by synthesis using pulse read optics |
| PCT/US2015/050376 Continuation WO2016044391A1 (en) | 2014-09-17 | 2015-09-16 | Sequencing by synthesis using pulse read optics |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20200123605A1 true US20200123605A1 (en) | 2020-04-23 |
Family
ID=55533783
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US15/512,441 Expired - Fee Related US10550428B2 (en) | 2014-09-17 | 2015-09-16 | Sequencing by synthesis using pulse read optics |
| US16/724,574 Abandoned US20200123605A1 (en) | 2014-09-17 | 2019-12-23 | Sequencing by synthesis using pulse read optics |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US15/512,441 Expired - Fee Related US10550428B2 (en) | 2014-09-17 | 2015-09-16 | Sequencing by synthesis using pulse read optics |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US10550428B2 (en) |
| EP (1) | EP3194643B1 (en) |
| CN (1) | CN107002293B (en) |
| CA (1) | CA2961743A1 (en) |
| ES (1) | ES2788692T3 (en) |
| WO (1) | WO2016044391A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016044391A1 (en) | 2014-09-17 | 2016-03-24 | Ibis Biosciences, Inc. | Sequencing by synthesis using pulse read optics |
| CN112673251A (en) * | 2019-05-31 | 2021-04-16 | 伊鲁米那股份有限公司 | Flow cell for selective deposition or activation of nucleotides |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6921636B1 (en) | 1991-09-04 | 2005-07-26 | Metrigen, Inc. | Method and apparatus for conducting an array of chemical reactions on a support surface |
| US5714330A (en) | 1994-04-04 | 1998-02-03 | Lynx Therapeutics, Inc. | DNA sequencing by stepwise ligation and cleavage |
| US5695934A (en) | 1994-10-13 | 1997-12-09 | Lynx Therapeutics, Inc. | Massively parallel sequencing of sorted polynucleotides |
| US5750341A (en) | 1995-04-17 | 1998-05-12 | Lynx Therapeutics, Inc. | DNA sequencing by parallel oligonucleotide extensions |
| US6969488B2 (en) | 1998-05-22 | 2005-11-29 | Solexa, Inc. | System and apparatus for sequential processing of analytes |
| EP1028970A1 (en) | 1997-10-10 | 2000-08-23 | President And Fellows Of Harvard College | Replica amplification of nucleic acid arrays |
| US6511803B1 (en) | 1997-10-10 | 2003-01-28 | President And Fellows Of Harvard College | Replica amplification of nucleic acid arrays |
| US6485944B1 (en) | 1997-10-10 | 2002-11-26 | President And Fellows Of Harvard College | Replica amplification of nucleic acid arrays |
| EP1054726B1 (en) * | 1998-02-11 | 2003-07-30 | University of Houston, Office of Technology Transfer | Apparatus for chemical and biochemical reactions using photo-generated reagents |
| US6787308B2 (en) | 1998-07-30 | 2004-09-07 | Solexa Ltd. | Arrayed biomolecules and their use in sequencing |
| AR021833A1 (en) | 1998-09-30 | 2002-08-07 | Applied Research Systems | METHODS OF AMPLIFICATION AND SEQUENCING OF NUCLEIC ACID |
| WO2001023610A2 (en) | 1999-09-29 | 2001-04-05 | Solexa Ltd. | Polynucleotide sequencing |
| US6936702B2 (en) | 2000-06-07 | 2005-08-30 | Li-Cor, Inc. | Charge-switch nucleotides |
| ATE546525T1 (en) | 2003-01-29 | 2012-03-15 | 454 Life Sciences Corp | NUCLEIC ACID AMPLIFICATION BASED ON BEAD EMULSION |
| GB2398383B (en) * | 2003-02-12 | 2005-03-09 | Global Genomics Ab | Method and means for nucleic acid sequencing |
| US7315019B2 (en) | 2004-09-17 | 2008-01-01 | Pacific Biosciences Of California, Inc. | Arrays of optical confinements and uses thereof |
| US7170050B2 (en) | 2004-09-17 | 2007-01-30 | Pacific Biosciences Of California, Inc. | Apparatus and methods for optical analysis of molecules |
| AU2006211150A1 (en) | 2005-01-31 | 2006-08-10 | Pacific Biosciences Of California, Inc. | Use of reversible extension terminator in nucleic acid sequencing |
| US20070141598A1 (en) | 2005-02-09 | 2007-06-21 | Pacific Biosciences Of California, Inc. | Nucleotide Compositions and Uses Thereof |
| US7805081B2 (en) | 2005-08-11 | 2010-09-28 | Pacific Biosciences Of California, Inc. | Methods and systems for monitoring multiple optical signals from a single source |
| US7405281B2 (en) | 2005-09-29 | 2008-07-29 | Pacific Biosciences Of California, Inc. | Fluorescent nucleotide analogs and uses therefor |
| US7763423B2 (en) | 2005-09-30 | 2010-07-27 | Pacific Biosciences Of California, Inc. | Substrates having low density reactive groups for monitoring enzyme activity |
| WO2007064597A2 (en) | 2005-11-28 | 2007-06-07 | Pacific Biosciences Of California, Inc. | Uniform surfaces for hybrid material substrates and methods for making and using same |
| US7998717B2 (en) | 2005-12-02 | 2011-08-16 | Pacific Biosciences Of California, Inc. | Mitigation of photodamage in analytical reactions |
| ES2648313T3 (en) | 2005-12-22 | 2017-12-29 | Pacific Biosciences Of California, Inc. | Polymerases for the incorporation of nucleotide analogs |
| WO2007075987A2 (en) | 2005-12-22 | 2007-07-05 | Pacific Biosciences Of California, Inc. | Active surface coupled polymerases |
| US7995202B2 (en) | 2006-02-13 | 2011-08-09 | Pacific Biosciences Of California, Inc. | Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources |
| US7692783B2 (en) | 2006-02-13 | 2010-04-06 | Pacific Biosciences Of California | Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources |
| US7715001B2 (en) | 2006-02-13 | 2010-05-11 | Pacific Biosciences Of California, Inc. | Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources |
| US20080050747A1 (en) | 2006-03-30 | 2008-02-28 | Pacific Biosciences Of California, Inc. | Articles having localized molecules disposed thereon and methods of producing and using same |
| US8975216B2 (en) | 2006-03-30 | 2015-03-10 | Pacific Biosciences Of California | Articles having localized molecules disposed thereon and methods of producing same |
| US7563574B2 (en) | 2006-03-31 | 2009-07-21 | Pacific Biosciences Of California, Inc. | Methods, systems and compositions for monitoring enzyme activity and applications thereof |
| WO2007149724A2 (en) | 2006-06-12 | 2007-12-27 | Pacific Biosciences Of California, Inc. | Substrates for performing analytical reactions |
| WO2007147110A2 (en) | 2006-06-16 | 2007-12-21 | Pacific Biosciences Of California, Inc. | Controlled initiation of primer extension |
| CA2662521C (en) | 2006-09-01 | 2016-08-09 | Pacific Biosciences Of California, Inc. | Substrates, systems and methods for analyzing materials |
| US20080080059A1 (en) | 2006-09-28 | 2008-04-03 | Pacific Biosciences Of California, Inc. | Modular optical components and systems incorporating same |
| WO2008051530A2 (en) | 2006-10-23 | 2008-05-02 | Pacific Biosciences Of California, Inc. | Polymerase enzymes and reagents for enhanced nucleic acid sequencing |
| US8551704B2 (en) | 2007-02-16 | 2013-10-08 | Pacific Biosciences Of California, Inc. | Controllable strand scission of mini circle DNA |
| GB2461026B (en) | 2008-06-16 | 2011-03-09 | Plc Diagnostics Inc | System and method for nucleic acids sequencing by phased synthesis |
| KR101107315B1 (en) | 2009-09-29 | 2012-01-20 | 한국과학기술연구원 | DNA sequence analysis method using a nucleoside triphosphate attached to a 3′-hydroxyl group as a reversible terminator |
| US20110311963A1 (en) | 2010-03-16 | 2011-12-22 | Life Technologies Corporation | Method and Apparatus for Addressable Flow Cells in Single Molecule Sequencing |
| US8865078B2 (en) | 2010-06-11 | 2014-10-21 | Industrial Technology Research Institute | Apparatus for single-molecule detection |
| US20120156100A1 (en) | 2010-12-20 | 2012-06-21 | Industrial Technology Research Institute | Apparatus for single molecule detection and method thereof |
| BR112014016846B1 (en) | 2012-01-13 | 2020-09-29 | Koninklijke Philips N.V | DEVICE FOR THE OPTICAL CONTROL OF AN ITERATIVE STEP REACTION TO DETERMINE A NUCLEIC ACID SEQUENCE BY SYNTHESIS AND METHOD FOR THE OPTICAL CONTROL OF AN ITERATIVE STEP REACTION TO DETERMINE A NUCLEIC ACID SEQUENCE |
| WO2014150851A1 (en) * | 2013-03-15 | 2014-09-25 | Ibis Biosciences, Inc. | Nucleotide analogs for sequencing |
| WO2016044391A1 (en) | 2014-09-17 | 2016-03-24 | Ibis Biosciences, Inc. | Sequencing by synthesis using pulse read optics |
-
2015
- 2015-09-16 WO PCT/US2015/050376 patent/WO2016044391A1/en not_active Ceased
- 2015-09-16 EP EP15841893.9A patent/EP3194643B1/en active Active
- 2015-09-16 CN CN201580062445.5A patent/CN107002293B/en not_active Expired - Fee Related
- 2015-09-16 CA CA2961743A patent/CA2961743A1/en not_active Abandoned
- 2015-09-16 US US15/512,441 patent/US10550428B2/en not_active Expired - Fee Related
- 2015-09-16 ES ES15841893T patent/ES2788692T3/en active Active
-
2019
- 2019-12-23 US US16/724,574 patent/US20200123605A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP3194643A4 (en) | 2018-04-25 |
| US20170247755A1 (en) | 2017-08-31 |
| ES2788692T3 (en) | 2020-10-22 |
| EP3194643B1 (en) | 2020-02-19 |
| CN107002293B (en) | 2020-12-08 |
| CA2961743A1 (en) | 2016-03-24 |
| CN107002293A (en) | 2017-08-01 |
| US10550428B2 (en) | 2020-02-04 |
| WO2016044391A1 (en) | 2016-03-24 |
| EP3194643A1 (en) | 2017-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220170091A1 (en) | Intermittent detection during analytical reactions | |
| US8143030B2 (en) | Intermittent detection during analytical reactions | |
| JP7332235B2 (en) | Methods of sequencing polynucleotides | |
| WO2010117804A2 (en) | Mostly natural dna sequencing by synthesis | |
| US11359236B2 (en) | DNA sequencing | |
| US20200123605A1 (en) | Sequencing by synthesis using pulse read optics | |
| EP2844772B1 (en) | Dna sequencing | |
| Lin et al. | Recent patents and advances in the next-generation sequencing technologies | |
| CN104364789A (en) | Methods and apparatuses for predicting risk of prostate cancer and prostate gland volume | |
| JP6482672B2 (en) | Improved droplet sequencing apparatus and method | |
| US20200123604A1 (en) | Dna sequencing | |
| Meis et al. | Near-Infrared Applications in DNA Sequencing and Analysis | |
| Calibasi et al. | DNA SEQUENCING TECHNOLOGIES USED IN THE MEDICAL FIELD | |
| Ronaghi et al. | A Bioluminometric Method of DNA Sequencing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: IBIS BIOSCIENCES, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ESHOO, MARK W.;CLEMENS, JOHN M.;HAYDEN, MARK A.;SIGNING DATES FROM 20170418 TO 20170421;REEL/FRAME:051520/0835 |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |